Cary Street Partners Asset Management’s Emergent Biosolutions EBS Stock Holding History

Cary Street Partners Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5	Closed	-$52	–	247
2023 Q1	$52	Buy	+5	New	+$60	﹤0.01%	397
2022 Q4	–	Sell	-5	Closed	–	–	451
2022 Q3	$0	Buy	+5	New	+$139	﹤0.01%	409

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cary Street Partners Asset Management's EBS Position: Q2 2023 in Review

Cary Street Partners Asset Management sold out of Emergent Biosolutions (EBS) in Q2 2023, closing a stake of 5 shares — an estimated $52 sold.

Cary Street Partners Asset Management first reported a position in EBS in Q3 2022 and held it in 2 quarters. The position peaked at $52 in Q1 2023. 183 funds tracked by Wall St. Rank hold EBS as of Q2 2023.

Cary Street Partners Asset Management reported no remaining Emergent Biosolutions position as of Q2 2023 after selling out during the quarter.
Cary Street Partners Asset Management sold 5 Emergent Biosolutions shares in Q2 2023, an estimated $52.
Cary Street Partners Asset Management first reported a position in Emergent Biosolutions in Q3 2022 and held it in 2 quarters.
Cary Street Partners Asset Management's Emergent Biosolutions position peaked at $52 in Q1 2023.
183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2023.

Based on Cary Street Partners Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.